45
DAFTAR PUSTAKA
1. Winer RL, Koutsy LA. Genital human papilomavirus infection. Dalam: Holmes KK, Sparling PF, Stamm WE, Piot P. Wasserheit JN, Corey L, Cohen MS, Watts DH, penyunting. Sexually Transmitted Disease. Edisi ke-4. New York: McGraw Hill; 2008.h.489-501
2. Murtiastutik D. Kondiloma akuminata. Dalam: Barakbah J, Lumintang H, Martodihardjo S, penyunting. Buku Ajar Infeksi Menular Seksual. Surabaya: Airlangga University Press; 2008.h.165-69
3. Zubier F. Kondiloma akuminata. Dalam: Daili FS, Makes BIN, Zubier F, Judanarso J, penyunting. Infeksi Menular Seksual. Edisi ke-3. Jakarta: Balai penerbit Fakultas Kedokteran Universitas Indonesia;2005.h.126-31
4. Center for Disease Control and Prevention. Sexually Transmitted Disease Treatment Guidelines 2010. Morbidity and Mortality Weekly Report.2010;59: 69-78
5. Monk BJ, Tewari KS. The spectrum and clinical sequellae of human papillomavirus infection. Gynecol Oncol.2007;107(2 Suppl 1):S6-13
6. Steben M, Duarte-Franco E. Human papillomavrus infection: Epidemiology and pathophysiology. Gynecol Oncol.2007;107(2 Suppl 1):S2-5.
7. Alba A, Cararach M, RRodriquez-Cerdeira C. The human papillomavirus (HPV) in human pathology; description, pathogenesis, oncogenic role, epidemiology and detection technique. The Open Dermatology Journal.2009;3:90-102
8. Hakim L. Biologi dan patogenesis human papiloma virus. PKB “New perspective
of sexually transmitted infection problems. Surabaya;2010.h.164-80
9. Herbert C, Melgert B, Laan JW, Faas M. New adjuvantes vaccines in pregnancy: what is known about their safety? Expert Rev Vaccines.2010; 9(12): 1411-22 10.Monia M, Fethi BA, Asma F, Hedi R. Giant condyloma in pregnancy. La Tunisie
Medicale.2013;91:422-3
11.Goncalves MAG, Donadi EA. Immune cellular response to HPV: current concepts. Braz J Infect.2004; 8(1):1-9
12.Stanley MA. Immune responses to human papilloma viruses. Indian J Med Res. 2009;130:266-76
13.Leto MGP, Santor Jr GF, Poro AM, Tomimori J. Human papillomavirus infection: etiopathogenesis, molecular biology and clinical manifestations. An Bras Dermatol.2011; 86(2): 306-17
14.Xu Y, Zhu KJ, Zhu N, Chen XZ, Cheng H. Expression of Foxp3+ CD4+ CD25+ regulatory T cells and Th1/Th2, Tc1/Tc2 profiles in the peripheral blood of patients with condyloma acuminatum. Clinical and Experimental Dermatology. 2008; 34: 229-35
15.Ljubojevic S, LipozencicGrgec DL, Prstatic R, Skerlev M, Mokos ZB. Human Papilloma Virus associated with genital infection. Coll Antropol.2008;32(3):989-97
16.Nelwan SR, Niode NJ, Kapantow MG. Profil kondiloma akuminata di Poliklinik Kulit dan Kelamin RSUP. Prof. Dr.R.D. Kandou Manado Januari 2012-
46
Desember 2012. Skripsi Fakultas Kedokteran Universitas Sam Ratulangi Manado Bagian/SMF Kulit dan Kelamin RSUP Prof. Dr.R.D. Kandou Manado.2014 17.Adriman Z, Rangkuti IF, Nadeak K. Karakteristik pasien kutil kelamin di RSUD.
Dr. Pirngadi Medan 2010-2012. Tesis Magister Fakultas Kedokteran Universitas Sumatera Utara.2014
18.Silitonga JT. Gambaran infeksi menular seksual di RRSUP. H. Adam Malik Medan tahun 2009. Karya Tulis Ilmiah Fakultas Kedokteran Universitas Sumatera Utara. 2011
19.Androphy EJ, Lowy DR. Warts. Dalam: Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffel DJ, penyunting. Fitzpatrick’s Dermatology in General medicine. Edisi ke-7. New York: McGraw Hill; 2008.h.1914-22
20.Dyment PG. Human Papillomavirus. Adolesent medicine: State of the Art Review.1996;7:167-73
21.Forcier M, Mussachhio N. An overview of human papillomavirus infection for the dermatologist: disease, diagnosis, management and prevention. Dermatologic therapy.2010;23:458-76
22.Man S. Human cellular immune responses against human papilloma viruses in cervical neoplasia. Expert Reviews in Molecular Medicine. 1998;1998:1-18 23.Sanclemente G, Gill DK. Human papillomavirus molecular biology and
pathogenesis. J Eur Acad Dermatol Venereol.2002;16(3):231-40
24.Conway MJ, Meyers C. Replication and assembly of Human papillomaviruses. J Dent Res.2009; 88(4): 307-17
25.Burd EM. Human papillomavirus and cervical cancer. Clin Micr Rev. 2003;16(1):1-17
26.Scheurer ME, Tortolero-Luna G, Adler-Storhz K. Human papillomavirus infection: biology, epidemiology and prevention. Int J Gynecol Cancer.2005;15:727-46
27.Bergot AS, Kassianos A, Frazer IH, Mittal D. New approaches to immunotherapy for HPV associated cancers. Cancers. 2011;3:3461-95
28.Egelkrout, Galloway DA. The biology of genital human papillomavirus. Dalam: Holmes KK, Sparling PF, Stamm WE, Piot P. Wasserheit JN, Corey L, Cohen MS, Watts DH, penyunting. Sexually Transmitted Disease. Edisi ke-4. New York: McGraw Hill; 2008.h.463-89
29.Frazer IH. Interaction of human papillomaviruses with the host immune system: A well evolved relationship. Virology. 2009;384:410-14
30.Carter JR, Ding Z, Rose BR. HPV infection and cervical disease: A review. Australian and New Zealand journal of obstetrics and gynaecology.2011;5(2):103-8
31.Kihara A, Kosgei JR, Rogena E, Amin M, Cheserem JE, Kiarie J. Vulvo-perianal giant condyloma accuminata (Buschke Loweinstein Tumor) in a HIV-infected woman: a case report. JOGECA.2012;24(2): 52-4
32.Yakasai IA, Abu Bakar IS, Ibrahim SA, Ayyuba R. Unusaul presentation of giant condyloma acuminate of the vulva- A case report and review literature. Anatom physiol. 2012; 86: 1-3
47
33.Kumar B, Gupta S. The acetowhite test in genital human papillomavirus infection in men: what does it add?. JEADV. 2001; 15: 27-9
34.Dias EP, Gouvea ALF, Eyer CL. Condyloma acuminatum: its histopathological pattern. Sao Paulo Medical Journal.1997; 115(2): 1383-9
35.Baseman JG, Koutsky LA. The epidemiology of human papillomavirus infections. Journal of clinical virology. 2005; 32: s16-24
36.Mariani L, Venuti A. HPV vaccine: an overview of immune response, clinical protection and new approaches for the future. Journal of translational medicine.2010;105:1-8
37.Heideman DAM, Snijders PJF, Berkhof J, Verheijen RHM, Helmerhorst TJM, Meijer CJLM. Vaccination against HPV: indications for women and the impact on cervical screening programme. BJOG.2008;115:938-46
38.Zajac AJ, Harrington LE. Immune response to viruses: cell-mediated immunity. Encyclopedia of Virology. 2008; 3: 70-7
39.Baratawidjaja KG, Rengganis I. Gambaran sistem imun. Dalam: Imunologi Dasar. Edisi ke-8. Jakarta: Balai Penerbit Fakultas Kedokteran Universitas Indonesia; 2009.h.27-56
40.Silling S, Wieland U, Werner M, Pfister H, Potthoff A, Kreuter A. Resolution of novel human papillomavirus induced warts after HPV vaccination. Emerging Infectious Diseases.2014;20(1):142-5
41.Bosire EM, Nyamache AK, Gicheru MM, Khamadi SA, Lihaha RW, Okoth V. Population specific reference ranges of CD3, CD4 and CD8 lymphocyte subsets among healthy Kenyans. AIDS Research and Therapy.2013;10(24):1-7
42.Abdelrazaq AA, Yousif WH, Wohaieb SA. Flow cytometric analysis of CD4 and CD8 cell subsets in some Iraqi patients with diabetes mellitus type 2. Current Research in Microbiology and Biotechnology. 2013;1(5):235-8
43.Hong K, Greer CE, Ketter N, Van Nest G, Paliard X. Isolation and characterization of human papillomavirus type 6 specific T cells infiltrating genital warts. J Virol. 1997; 71(9): 6427-32
44.Stanley MA. Epithelial cell responses to infection with human papillomavirus. Clinical Microbiology Reviews.2012;25(2): 215-22
45.Leiding JW, Holland SM. Warts and All: HPV in primary immunodeficiencies. J Allergy Clin Immunol.2012;130(5):1030-48
46.Meliala SU. Respon imunitas seluler pada penderita kondiloma akuminata yang sudah lama diderita. Tesis. Bagian Ilmu Kesehatan Kulit dan Kelamin FK USU. 2005
47.Israita P, Lumintang H, Murtiatutik D. Profil penderira baru kondiloma akuminata di Divisi Penyakit Menular bSeksual URJ Kesehatan Kulit dan Kelamin RSUD Dr. Soetomo Surabaya periode 2006-2008. Berkala Ilmu Kesehatan Kulit dan Kelamin. 2011;23(3):216-21
48.Hidayat T. Deteksi Human papilloma virus tipe 6 dan 11 pada lesi dan peri lesi kondiloma akuminatum dengan polymerase chain reaction. Tesis. Bagian Ilmu Kesehatan Kulit dan Kelamin FK Universitas Andalas. 2012
48
49.Kyriakis KP, Hadjivvassiliou M, Paparizos VA, Riga P, Katsamba A. Determinants of genital wart case detection rates among STD clinic attendees in Athens, Greece. Int J Dermatol. 2005;44:650-3
50.Chang GJ, Welton ML. Human papillomavirus, condyloma acuminate and anal neoplasia. Clin colon rectal surg.2004;17(4):221-30
51.Sung JH, Ahn EJ, Oh H, Park SH. Association of immune status recurrent anal condylomata in human immunodeficiency virus-positive patients. J Korean Suc Colorectal. 2012;78(1):294-8
52.Thappa DM, Senthilkumar M, Laxmisha C. Anogenital wart-an overview. Indian J Sex Transm Dis. 2004;25(2):55-66
53.Krebs HB, Denny L. Human papillomavirus infection and genital tract cancer. The Global Library of Women S Medicine. Diunduh dari: www.glown.com/section_view/heading/Human%20Papillomavirus%20Infection %20and%20Genital%20Tract%20Cancer/item/226#sectionView. Pada tanggal 2 April 2016
54.Castellsague X, Cohet C, Puig-Tintore L, Acebes LO, Salinas J, Martin MS et all. Epidemiology and cost of treatment of genital warts in Spain. European Journal of Public Helath. 2008;19(1):106-10
55.Untung SP. Kondiloma akuminatum penyakit hubungan seksual penyerta dan respon imun seluler. Laporan penelitian. Program Pendidikan Dokter Spesialis Ilmu Penyakit Kulit dan Kelamin FK UI. 1988
56.Dong-Xian L, Wen J, Xing-ping C, Ying-ling C, Dong-liang Y. Expression of cytokine in CD8+ T lymphocyte of the peripheral blood of patients with condyloma acuminatum. Chinese Journal of Dermatology. 2007;40(11):674-5 57.Stanley M. Immune responses to human papillomavirus. JVAD.
2006;24(1):216-22
58.Saiag P, Bauhofer A, Bouscarat F, Aquilina C, Ortonre JP, Dupin N. Imiquimod 5% cream for external genital or perianal warts in human immunodeficiency virus- positive patients treated with highly active antiretroviral therapy: an open-label, non comparative study. BJD. 2009;161:904-9
59.Hibma MH. The immune response to papillomavirus during infection persistence and regression. The Open Virology Journal. 2012;6(2):241-8
60.Luu HN, Amirian ES, Chan W, Beasley RP, Piller LB, Scheuner ME. Cd4+ cell count and HIV load as predictors of size of anal warts over time in HIV infected women. JID. 2012;205:579-85
61.Opaneye AA. The cellular immune system in female patients with or without genital warts: a study of peripheral white blood cell components. International journal of STD & AIDS. 1999;10:815-6
62.Nambudiri VE, Mutyambizi K, Walls AC, Fisher DC, Bleday R, Saavedra AP. Successful treatment of perianal giant condyloma acuminatum in an immunocompromised host with systemic interleukin 2 an topical cidofovir. JAMA Dermatol. 2013;149(9):1068-70
